Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ALKS 2680 / Alkermes
Vibrance-1, NCT06358950: A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects with Narcolepsy Type 1 (ALKS 2680-201)	Recruiting	2	80	US, RoW	ALKS 2680, Placebo	Alkermes, Inc.	Narcolepsy Type 1	07/25	07/25
Vibrance-2, NCT06555783: A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2	Recruiting	2	80	US	ALKS 2680, Placebo	Alkermes, Inc.	Narcolepsy Type 2	08/25	09/25